In Uruguay a new treatment has been approved antiviral from the laboratory Pfizer intended for people with Covid-19 and risk factors, which can prevent severe forms of the disease and hospitalizations. This medicine can only be prescribed by a doctor and is complemented by the importance of continuing to be vaccinated. The current situation of the Covid-19 in the country is under control, but there is a increase in positivity rate and it is necessary to continue taking preventive measures.
He Ministry of Public Health (MSP) approved Pfizer’s oral antiviral compound created especially to treat the disease caused by SARS-CoV-2 virus. It is an antiviral called nirmatrelvirwhich is used in combination with the ritonavirand is indicated for those adults who, faced with Covid-19, present a high risk of developing complications or, even, Death risk.
The drug is supplied by prescription and is recommended for patients with comorbidities within the first five days of the onset of symptoms.
the infectologist edward savioadvisor to the Immunization Committee of the Pan American Association of Infectious Diseasesspoke to the media at an event in which Pfizer presented news on the treatment of the Sars-CoV-2 coronavirus in Uruguay, where he participated scope.com. “Covid-19 continues to impact Uruguay, without overloading the system, without such serious forms, with a lower level, but we must not ignore that it exists and therefore if we can prevent it we must do so,” he pointed out, adding that the country did not enter in a endemic still.
Since the Covid-19 health emergency was declared in Uruguay, on March 13, 2020, almost 900,000 positive cases of coronavirus have been registered throughout the country and more than 7,000 deaths from this cause. “Although today the reports do not show a significant increase in the number of cases, Covid-19 is here to stay and it requires special attention in those people with risk factors that can develop serious illness”, said the specialist.
“Vaccination is completely essential, because in reality if we are as we are today, in a position, shall we say, comfortable, we cannot ignore that it is partly thanks to vaccination. Many people with a fifth dose, with a fourth dose, the fact of having a treatment does not have to discourage vaccination. First the vaccine and then if the vaccine doesn’t work at all and someone gets sick, we have the antivirus,” he added.
Data
- The drug is already available in Latin America in Chili, Mexico and Dominican Republic.
- Its sale cost is around 500 dollars, so it is estimated that it will be the mutuals and health institutions that will buy it to provide it to users.
- The current availability is in drugstores, but it could be sold in pharmacies with a prescription.
Source: Ambito
